𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer

✍ Scribed by Nicholson, S; Halcrow, P; Sainsbury, JRC; Angus, B; Chambers, P; Farndon, JR; Harris, AL


Book ID
109836052
Publisher
Nature Publishing Group
Year
1988
Tongue
English
Weight
940 KB
Volume
58
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase 2 randomized trial of primary endo
✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/